Tangji medical received tens of millions of financing from bv Baidu venture capital


Recently, Hangzhou Tangji Medical Technology Co., Ltd. (hereinafter referred to as Tangji medical) announced that it has completed tens of millions of financing in the first quarter of 2021. This financing is led by bv Baidu venture capital, followed by investors such as longmafeng venture capital and Dingxin capital. According to Zuo Yuxing, founder and CEO of Tangji medical, the funds raised this time will provide support for the ongoing clinical research and production line construction of “gastric bypass stent system” of Tangji medical.
Tangji medical, founded in 2016, is a high-tech enterprise focusing on the research and development of new treatment methods for metabolic diseases such as obesity, diabetes and fatty liver. At present, it mainly carries out non-invasive implantation research for the treatment of metabolic diseases.